Vasopressin ( DrugBank: Vasopressin )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
210	単心室症	2

210. 単心室症

---

臨床試験数 : 51 /  薬物数 : 53 - (DrugBank : 22) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 67

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03088345 (ClinicalTrials.gov)	March 6, 2017	28/2/2017	Early Use of Vasopressin in Post-Fontan Management	Use of Arginine Vasopressin in Early Postoperative Management After Fontan Palliation	Circulatory Perfusion Disorder;Congenital Heart Disease;Single-ventricle	Drug: Vasopressin, Arginine;Drug: Placebo	Medical College of Wisconsin	NULL	Completed	N/A	18 Years	All	20	Phase 2/Phase 3	United States
2	NCT02975999 (ClinicalTrials.gov)	December 2016	22/9/2016	Use of Vasopressin Following the Fontan Operation	Use of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter Studies	Pleural Effusion;Single-ventricle	Drug: Vasopressin;Drug: Normal Saline	Advocate Health Care	NULL	Withdrawn	18 Months	7 Years	All	0	Phase 2/Phase 3	United States